Sangamo Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everyone. My name is Gena Wang. I'm Senior Biotech Analyst at the Barclays. Welcome to Barclays Global Healthcare Conference. It is my great pleasure to introduce our next presenting company, Sangamo Therapeutics.
With us, we have Sandy Macrae, Chief Executive Officer. Sandy, why don't you give a brief intro and then we will dive into the questions?
Thank you, Gena, and thank you to everyone. It's always a pleasure to come to Miami and the Barclays conference, and to see you again, Gena.
So Sangamo is a fascinating company that's executing and delivering on its promise. We have 3 late phase assets, hemophilia with Pfizer, where they've guided that they will file a BLA in the second half of next year. Fabry, where we're showing some great data that I'm sure you want to talk about, and we will hope to move into Phase III at the end of this year. And sickle cell, where we announced
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
